Evidence-based follow-up

Spanberger T. Evidence-based follow-up in patients with Hodgkin’s lymphoma and aggressive B-cell non-Hodgkin’s lymphoma. memo. 2020. https://doi.org/10.1007/s12254-020-00570-8. Stierer M. Evidence-based follow-up for breast cancer. memo. 2020. https://doi.org/10.1007/s12254-019-00531-w. Maglione M, Perathoner A. Evidence-based follow-up in colorectal cancer—quo vadis? memo. 2020. https://doi.org/10.1007/s12254-019-00553-4. Watzka S. Evidence-based follow-up in non-small-cell lung cancer. memo. 2020. https://doi.org/10.1007/s12254-019-00566-z. Ng C, Pircher A, Augustin F, Kocher F. Evidence-based follow-up in lung cancer?Focusing on the risk group of recently operated patients. memo. 2020. https://doi.org/10.1007/s12254-020-00575-3. Mayrhofer K, Niedersüß-Beke D. Evidence-based follow-up in renal cell carcinoma. memo. 2020. https://doi.org/10.1007/s12254-019-00540-9.